Cargando…
A brief review and clinical evidences of teriparatide therapy for atypical femoral fractures associated with long-term bisphosphonate treatment
The risk of bisphosphonate (BP)-associated atypical femur fracture (AFF) has markedly increased over recent decades due to suppression of bone turnover, accumulation of structural micro-damage and reduction of bone remodeling consequent to long-term BP treatment. These medications further delay bone...
Autores principales: | Gao, Jianpeng, Liu, Xiao, Wu, Xiaoyong, Li, Xiaoya, Liu, Jianheng, Li, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852062/ https://www.ncbi.nlm.nih.gov/pubmed/36684309 http://dx.doi.org/10.3389/fsurg.2022.1063170 |
Ejemplares similares
-
Atypical femoral fractures and bisphosphonates
por: Jawad, Ali S. M.
Publicado: (2017) -
Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment
por: Yeh, Wen-Ling, et al.
Publicado: (2017) -
Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy
por: Dózsai, Dávid, et al.
Publicado: (2020) -
Long term bisphosphonate therapy & atypical femoral fractures: A word of caution
por: Reddy, Sagili Vijaya Bhaskar
Publicado: (2014) -
Two Cases of Periprosthetic Atypical Femoral Fractures in Patients on Long-Term Bisphosphonate Treatment
por: Miura, Takanori, et al.
Publicado: (2019)